Avident Health LLC and Unite for HER have been awarded an independent quality improvement grant funded by Pfizer Inc. and the National Comprehensive Cancer Network (NCCN). The grant will support a collaborative project deploying Avident Health's MyNavigator digital platform to improve care for patients with metastatic breast cancer (mBC). This initiative matters because it addresses critical gaps in communication and support that occur between clinic visits, potentially leading to better treatment adherence, reduced complications, and improved quality of life for patients and their families.
Metastatic breast cancer requires complex, ongoing management where adherence to treatment, symptom monitoring, and whole-person supportive care are essential. Yet patients and their loved ones often struggle to navigate clinical guidelines and access community resources outside of appointments. The MyNavigator platform aims to bridge this gap by serving as an interactive, home-based companion. It delivers tailored education aligned with NCCN Guidelines for Patients, translating complex clinical pathways into accessible modules tailored to each patient's journey. This empowers patients to participate actively in informed decision-making with their clinical teams.
Additionally, the platform streamlines access to Unite for HER's free integrative services, such as nutrition counseling, fresh food delivery, mental health counseling, and evidence-based therapies. By integrating these resources directly into daily navigation prompts, patients can easily utilize supportive care. The initiative also uniquely engages informal caregivers—family members and daily care partners—by including them in a secure communication loop, providing them with education and early symptom alerts to support treatment adherence at home. Furthermore, the platform captures patient-reported check-ins and symptom trends to alert clinical teams early, preventing avoidable complications and reducing acute care utilization.
Dr. Maen Farha of Avident Health emphasized the importance of continuous support: "Navigating metastatic breast cancer is a daily reality that extends far beyond the four walls of the clinic. By combining the proactive digital coordination of MyNavigator with Unite for HER's exceptional integrative services and NCCN's gold-standard guidelines, we are creating a continuous circle of support that empowers patients, supports clinical teams, and actively engages the family caregivers who are vital to treatment success." Sue Weldon, Founder and CEO of Unite for HER, added, "Collaborating with Avident Health on the MyNavigator platform enables us to reach patients and their families directly at the exact moment they need guidance, removing barriers to our integrative nutrition, wellness, and emotional support resources."
The project will measure key quality improvement endpoints over the grant period, including improvements in patient knowledge concordance with NCCN Guidelines, rates of supportive service utilization, patient-reported decisional conflict, and therapy adherence metrics. For more information on Avident Health, visit www.avidenthealth.com. To learn more about Unite for HER, visit www.uniteforher.org. Details about NCCN can be found at www.nccn.org.
